Navigation Links
Research in which the University of Navarra participated provides new clues to causes of leukemia
Date:6/1/2010

This release is available in Spanish.

The University of Navarra, together with the University of Oxford and three other European centres, are taking part in a project to discover the origin of myelodysplasia, an ailment with a predisposition to develop into leukaemia. In the work, patients from 19 hospitals in the north of Spain including the University Hospital of Navarra - were analysed, as well as from England, Italy, Sweden and Germany.

The aim of the research, published recently in the Leukemia journal, is to look for molecular-level alterations genetic mutations, etc. that enable the development of new therapeutic targets for the treatment of leukaemia, and provide, moreover, a tool for monitoring the progress of patients subjected to specific treatment.

There are currently very different treatments for the group of ailments that we know as leukaemia and that are caused by different alterations. The problem lies in that they cannot now be classified solely with systems based on clinical symptomatology, given that in some cases patients do not manifest any alteration that makes this classification useful from a therapeutic perspective. Consequently, it has to be observed in greater detail at a molecular level.

In this way, the research team at the University of Navarra confirmed that the presence of mutations in a determined gene is associated with more serious forms of leukaemia, giving rise to the possibility of a relation between these mutations and the advancing to the most serious stage of the ailment. Moreover, this gene is linked to the mechanisms that regulate the interaction between genes and the environment that surrounds us. In short, this is another finding that opens new doors to identifying the disease at its early stages.


'/>"/>

Contact: Oihane Lakar
o.lakar@elhuyar.com
34-943-363-040
Elhuyar Fundazioa
Source:Eurekalert

Page: 1

Related biology news :

1. Researchers find gene linked to birth defects
2. Yale researchers develop test to identify best sperm
3. First Arizona Strides for Life event nets $25,000 for TGen research
4. Canadian research examines effects of scientific claims on oil
5. Consent forms for research: Have they improved in 25 years?
6. DFG approves 12 new collaborative research centers
7. Medical researchers discovery may explain how certain cancers develop
8. UT Southwestern researchers use novel sperm stem-cell technique to produce genetically modified rats
9. UCI researchers create retina from human embryonic stem cells
10. Discovery may lead to safer drinking water, cheaper medicine: Queens University researchers
11. Researchers discover new mechanism for clearing blockages from smallest blood vessels
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2015)... JOSE, Calif. , July 9, 2015 ... the leading developer of human interface solutions, ... technology, the industry,s first fully hardware encapsulated ... Match-in-Sensor secure authentication technology is literally off ... storage and biometric matching within the fingerprint ...
(Date:7/8/2015)... SAN DIEGO , July 8, 2015 /PRNewswire/ ... of cell-free molecular diagnostics, today announced the launch ... of the Company,s Precision Cancer Monitoring℠ (PCM) technology ... patients receiving one or a combination of the ... and Opdivo® (nivolumab), a PD-1 inhibitor. The 50-patient ...
(Date:7/7/2015)... 2015  Based on its recent analysis of ... Credence ID, LLC with the 2015 Asia-Pacific ... Year Award. Credence ID has developed a low-cost, ... of offering enrollment and identification solutions to the ... was formed by experts from the mobile biometrics ...
Breaking Biology News(10 mins):Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5
... Bethesda, MD The Federation of American Societies for ... the Science Research Conference (SRC): Melatonin Biology: Actions & ... Biology: Actions & Therapeutics is an important and unique ... as a cytoprotective molecule and a physiological marker of ...
... research team coordinated at the IRCM in Montral found ... Dr. Tarik Mry, the IRCM,s President and Scientific Director, ... "Achilles, heel" and could be targeted to develop a ... current treatments such as chemotherapy and radiation therapy. The ...
... a common element but is found in old paints ... piping, water, and the atmosphere from lead-containing vehicular fuels, ... but also causes seemingly trivial symptoms such as headaches. ... damage to the organs, the kidneys in particular, and ...
Cached Biology News:Researchers discover 'Achilles' heel' for lymphoid leukemia 2Is lead poisoning behind some juvenile crime? 2
(Date:7/28/2015)... July 28, 2015 Seahorse Bioscience, the ... is the provider of XF Technology which is ... research areas. As the links between mitochondrial function ... metabolism is escalating rapidly.   Recently, ... Nature Publishing Group (NPG) featuring XF Technology, including ...
(Date:7/28/2015)... , July 21, 2015 ... has announced the addition of the "Analysis ... report to their offering. Globally, flow ... including immuno-phenotyping, cell proliferation, cancer, and stem cells. ... clinical applications primarily because of demand from underdeveloped ...
(Date:7/28/2015)... ... ... VetStem Biopharma will be offering weekly private guided tours of our new facility, ... tour and course will be given every Wednesday at 6pm to local interested veterinarians ... are welcome to attend with their veterinarian as well. Participants will be able to ...
(Date:7/28/2015)... Tauriga Sciences, Inc. (OTCQB:  TAUG) or ("Tauriga" ... announced that its stockholders approved an increase in the ... Company from 1,000,000,000 to 2,500,000,000 at its Special Meeting ... Law Offices of Nixon Peabody LLP in Midtown Manhattan ... 480,655,929 shares of common stock represented either by proxy ...
Breaking Biology Technology:XF Technology Used to Demonstrate Feasibility of Stem Cell Regenerative Technique 2XF Technology Used to Demonstrate Feasibility of Stem Cell Regenerative Technique 3Analysis of the Global Flow Cytometry Market 2012-2018 with a 2014 Base Year and a 2015-2018 Forecast Period 2VetStem Biopharma weekly veterinary continuing education classes and GMP manufacturing facility tour 2Tauriga Sciences, Inc. Stockholders Approve Increase In Authorized Common Stock 2Tauriga Sciences, Inc. Stockholders Approve Increase In Authorized Common Stock 3
... 16% of U.S. Cardiology Offices ... Importance, SAN DIEGO, Feb. 19 CardioDynamics ... cardiography (ICG),technology, today announced that the Company,s BioZ ... ACCEL audio series., ACCEL is the American ...
... Studies Leading to FDA Application for Stem Cell Therapy ... Feb. 19 Families of,Spinal Muscular Atrophy (FSMA); a ... California Stem Cell, Inc. (CSC) are pleased,to announce a ... SMA,to human clinical trials. The specific set of animal ...
... 19 /PRNewswire-FirstCall/ - AEterna Zentaris Inc.,(NASDAQ: AEZS , ... and oncology, today announced that its President and CEO,David ... the Roth Capital,Partners 20th Annual OC Growth Stock Conference ... Ballroom of the Ritz Carlton Laguna Niguel in Dana,Point, ...
Cached Biology Technology:CardioDynamics BioZ(R) ICG Technology Featured in American College of Cardiology (ACC) Audio Series 2CardioDynamics BioZ(R) ICG Technology Featured in American College of Cardiology (ACC) Audio Series 3Families of Spinal Muscular Atrophy; University of California, Irvine Stem Cell Scientist; and California Stem Cell Announce Collaboration for Safety Studies for Stem Cell Therapy in Spinal Muscular Atrophy 2Families of Spinal Muscular Atrophy; University of California, Irvine Stem Cell Scientist; and California Stem Cell Announce Collaboration for Safety Studies for Stem Cell Therapy in Spinal Muscular Atrophy 3
a1-Antitrypsin (human, alpha-1 AT)...
... to study co-translational and initial post-translational ... as signal peptide cleavage, membrane insertion, ... examined by the translation of the ... presence of these microsomal membranes. In ...
... Mo Bio luciferase assay. Mo Bio Laboratories offers ... allow you to certify your products ATP-Free with ... to deliver them to your customers in a ... is 3.5 x 10-12 /l, which will allow ...
... Biomedical Photometrics Inc. (Waterloo, Ontario, Canada) and ... collaborated to develop a fluorescence reader for ... DNAscope AT is based on BPIs patented ... reads up to six ArrayTubes in sequence ...
Biology Products: